Rheumatology Doctors in Decatur, GA Accepting Medicare

7 Rheumatology doctors found. Showing 1 - 7

Dr. Gary Robert Botstein, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2712 N Decatur Rd, Decatur, GA 30033 Phone: 404-299-0187    Fax: 404-292-2766

Dr. Michael A. Friedman, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2784 N Decatur Rd Ste 150, Decatur, GA 30033 Phone: 404-299-8600    Fax: 404-299-0561

Jefrey D Lieberman, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2680 Lawrenceville Hwy Ste 201, Decatur, GA 30033 Phone: 404-296-4911    Fax: 404-296-1512

Emily Peninger, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 2680 Lawrenceville Hwy Ste 201, Decatur, GA 30033 Phone: 404-296-4911    Fax: 404-296-1512

Dr. Sanford Stuart Hartman, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2712 North Decatur Road, Decatur, GA 30033 Phone: 404-292-5222    Fax: 404-294-9535

Dr. Ferhana Najam, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2712 N Decatur Rd, Decatur, GA 30033 Phone: 404-299-0187    Fax: 404-292-2766

Ayesha Abdulkadar Iqbal, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 1670 Clairmont Rd, Dept. Of Rheumatology 111, Decatur, GA 30033 Phone: 404-321-6111

News Archive

Researchers explore impact of nutrients, probiotics before and during pregnancy on mothers and babies

Researchers in the United Kingdom (Southampton), Singapore and New Zealand (Auckland) from the EpiGen Global Research Consortium are to trial the use of a combination of nutrients and probiotics before and during pregnancy in a bid to improve the health of mothers and their babies.

GTx to continue two pivotal Phase III clinical trials of enobosarm

GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.

Medicinal chemistry paper related to the discovery of CUDC-101 published

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR and Her2 inhibitor, was published online in the Journal of Medicinal Chemistry and also will be published in an upcoming print version of the journal.

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.

Read more Medical News

› Verified 7 days ago